Cash & equivalents decreased 51.6%
Cash & equivalents changed -51.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -51.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +2525 basis points from the comparable as-filed period.
Debt changed +236.2% from the comparable as-filed period.
Revenue changed +46.9% from the comparable as-filed period.
Inventory / revenue changed +392 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +61.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed +46.8% from the comparable as-filed period.
Operating income changed -7.2% from the comparable as-filed period.
Net income changed -5.7% from the comparable as-filed period.
Research & development changed +2.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.